China Biotech Services Holdings Limited (HKG:8037)
Hong Kong · Delayed Price · Currency is HKD 0.7100
-0.0300 (-4.05%)
At close: Jan 30, 2026
HKG:8037 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -150.24 | -198.15 | -95.45 | 258.09 | 19.39 | 30.17 |
Depreciation & Amortization | 21.42 | 21.42 | 55.58 | 66.4 | 68.11 | 40.34 |
Loss (Gain) From Sale of Assets | 0.11 | 0.11 | -0.3 | -2.78 | - | 1.99 |
Asset Writedown & Restructuring Costs | 84.57 | 84.57 | 21.19 | 1.72 | 0.19 | - |
Loss (Gain) From Sale of Investments | - | - | - | -2.71 | -0.49 | -2.03 |
Loss (Gain) on Equity Investments | - | - | 7.68 | 4.18 | - | - |
Stock-Based Compensation | 0.3 | 0.3 | 1.89 | 2.02 | 5.25 | 9.11 |
Provision & Write-off of Bad Debts | 0.68 | 0.68 | -1.14 | 3.9 | 0.52 | 0.23 |
Other Operating Activities | 32.79 | -9.9 | -295.23 | 587.43 | 173.34 | 166.56 |
Change in Accounts Receivable | -33.74 | -33.74 | 724.98 | -664.23 | -64.92 | -22.13 |
Change in Inventory | 0.21 | 0.21 | -2.22 | -13.99 | -2.41 | -2.52 |
Change in Accounts Payable | -17.4 | -17.4 | -232.89 | 237.1 | -158.27 | 197.38 |
Change in Other Net Operating Assets | - | - | 1.44 | 7.81 | 0.07 | -0.1 |
Operating Cash Flow | -61.29 | -151.89 | 191.72 | 482.75 | 40.51 | 422 |
Operating Cash Flow Growth | - | - | -60.28% | 1091.82% | -90.40% | - |
Capital Expenditures | -51.65 | -51.65 | -59.41 | -108.17 | -12.22 | -126.6 |
Sale of Property, Plant & Equipment | 0.04 | 0.04 | 0.37 | 0.03 | - | 0.2 |
Divestitures | - | - | -0.04 | 5.37 | - | 0.13 |
Investment in Securities | 3.38 | 3.38 | 7.14 | -11.8 | 4.08 | - |
Other Investing Activities | 39.16 | 0.46 | -2.49 | -141.75 | 0.01 | 0.02 |
Investing Cash Flow | -9.07 | -47.77 | -54.43 | -256.31 | -8.12 | -126.25 |
Short-Term Debt Issued | - | 103.58 | 31.05 | 4.08 | 22.3 | 10.28 |
Long-Term Debt Issued | - | - | - | 38.98 | - | 76.28 |
Total Debt Issued | 103.58 | 103.58 | 31.05 | 43.05 | 22.3 | 86.56 |
Short-Term Debt Repaid | - | -26.89 | - | -8.15 | -12.05 | -23.94 |
Long-Term Debt Repaid | - | -9.03 | -11.2 | -10.53 | -53.74 | -10.49 |
Total Debt Repaid | -35.92 | -35.92 | -11.2 | -18.68 | -65.8 | -34.43 |
Net Debt Issued (Repaid) | 67.66 | 67.66 | 19.86 | 24.37 | -43.5 | 52.13 |
Issuance of Common Stock | 4.74 | 4.74 | - | - | - | - |
Repurchase of Common Stock | - | - | -3.64 | -2.99 | -4.31 | -4.51 |
Common Dividends Paid | - | - | -9.63 | - | - | - |
Other Financing Activities | -20.03 | 75.4 | -162.39 | -303.34 | -218.8 | -3.68 |
Financing Cash Flow | 52.38 | 147.81 | -155.8 | -281.96 | -266.61 | 43.94 |
Foreign Exchange Rate Adjustments | -3.97 | -1.32 | -2.18 | -2.26 | 0.25 | -0.67 |
Net Cash Flow | -21.95 | -53.17 | -20.68 | -57.78 | -233.99 | 339.02 |
Free Cash Flow | -112.94 | -203.54 | 132.31 | 374.58 | 28.29 | 295.4 |
Free Cash Flow Growth | - | - | -64.68% | 1224.12% | -90.42% | - |
Free Cash Flow Margin | -146.80% | -288.67% | 62.41% | 20.23% | 4.54% | 45.05% |
Free Cash Flow Per Share | -0.12 | -0.21 | 0.14 | 0.39 | 0.03 | 0.30 |
Cash Interest Paid | 5.87 | 5.87 | 6.39 | 3.83 | 3.29 | 5.73 |
Cash Income Tax Paid | - | -1.4 | 243.46 | 1.84 | -0.06 | 0.78 |
Levered Free Cash Flow | 9.89 | -3.65 | 57.36 | 186.61 | 25.28 | 250.68 |
Unlevered Free Cash Flow | 25.37 | 6.93 | 60.68 | 188.8 | 29.37 | 254.74 |
Change in Working Capital | -50.93 | -50.93 | 491.3 | -433.31 | -225.53 | 172.64 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.